Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $2.9 Million - $12 Million
10,363,108 New
10,363,108 $3.42 Million
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $19,814 - $28,149
15,726 Added 66.94%
39,218 $66,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $37,822 - $59,669
23,492 New
23,492 $42,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $447,053 - $2.29 Million
612,402 New
612,402 $1.91 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.